type here...
type here...
START FREE TRIAL

Ishan M.

Is Amazon’s $50 Billion OpenAI Deal Really About AI — Or Just AWS Market Share?

Consumer & Retail Ishan M. -
Amazon is reportedly negotiating a $50 billion investment into OpenAI, a potential anchor in a $100 billion funding round....

Is Pinterest Shrinking or Scaling? THIS AI SHIFT Tells the Story!

Technology & AI Ishan M. -
Pinterest (NYSE:PINS) is the latest tech player to join the layoff wave, announcing plans to reduce its workforce by...

Gold & Silver Are Rallying — But The REAL Signal Is The Split!

Miscellaneous Ishan M. -
Gold has pushed decisively above the psychological threshold that dominated market chatter, while silver has delivered explosive moves followed...

Fundamental Financial Concepts For Stock Analysis: The Secret to 10x Returns?

Blog Ishan M. -
Introduction Welcome to the world of stock analysis. It can feel like walking into a foreign country where everyone speaks...

A Valuation Multiples Guide In Equity Research: EV/EBITDA, EV/EBIT & Price To Book

Blog Ishan M. -
If you spend any time in equity markets, you know how quickly conversations drift toward “cheap” and “expensive.” Most...

Amazon Just Unleashed Its Biggest Grocery Expansion Yet—Here’s What’s at Stake

Consumer & Retail Ishan M. -
Amazon's (NASDAQ:AMZN) bold move to expand same-day perishable grocery delivery to over 2,300 U.S. cities is now intersecting with...
spot_imgspot_img

Mirum Bluejay Acquisition Unlocks Rare Disease Gold!

Healthcare Ishan M. -
Mirum Pharmaceuticals (NASDAQ:MIRM) is making big moves. In early December 2025, the company announced its plan to acquire privately...

Meta Metaverse Budget Cuts Aren’t Calming Wall Street!

Technology & AI Ishan M. -
Meta just slashed its metaverse budget by up to 30%—and yet, investors barely blinked. In fact, shares are still...

Apple vs Nvidia AI Strategy: Who’s Winning Now?

Technology & AI Ishan M. -
In the chaotic churn of AI-driven market narratives, a new pecking order is quietly taking shape. As of late...

Novartis Gene Therapy Approval: A New Multi-Billion Dollar Market?

Healthcare Ishan M. -
Novartis just scored a big win with a major Novartis gene therapy approval —and it could reshape the gene...

Google vs Nvidia AI Chips: Silicon War Begins

Technology & AI Ishan M. -
Alphabet's rise in artificial intelligence isn't just about fancy models or bigger search engines anymore. In a bold new...

Baptista Research is a financial research house focused on the U.S. markets. We cover the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms.

Company

Headlines

Pfizer Takes On Eli Lilly & Novo: Who Gets OUTPLAYED in the Obesity Arms Race?

0
Pfizer just released mid-stage data from its Metsera-acquired obesity...

Is The Devon + Coterra $21 Billion Merger About Growth — Or Running Out of Rock?

0
Devon Energy just announced a $21.4 billion all-stock acquisition...

Is Apple Outflanking Meta With This Q.AI Move?

0
Apple acquired Israeli startup Q.AI for close to $2B,...

Is Amazon’s $50 Billion OpenAI Deal Really About AI — Or Just AWS Market Share?

0
Amazon is reportedly negotiating a $50 billion investment into...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 Baptista Research. All rights reserved.